These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 35415751)
1. Mechanisms of podocyte injury and implications for diabetic nephropathy. Barutta F; Bellini S; Gruden G Clin Sci (Lond); 2022 Apr; 136(7):493-520. PubMed ID: 35415751 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy. Barutta F; Bellini S; Kimura S; Hase K; Corbetta B; Corbelli A; Fiordaliso F; Bruno S; Biancone L; Barreca A; Papotti MG; Hirsh E; Martini M; Gambino R; Durazzo M; Ohno H; Gruden G Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195 [TBL] [Abstract][Full Text] [Related]
3. Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy. Naito S; Nakayama K; Kawashima N Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511118 [TBL] [Abstract][Full Text] [Related]
4. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668 [TBL] [Abstract][Full Text] [Related]
5. Emerging role of podocyte autophagy in the progression of diabetic nephropathy. Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953 [TBL] [Abstract][Full Text] [Related]
6. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases. Szabó T; Ambrus L; Zákány N; Balla G; Bíró T Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740 [TBL] [Abstract][Full Text] [Related]
7. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects. Li X; Zhang Y; Xing X; Li M; Liu Y; Xu A; Zhang J Biomed Pharmacother; 2023 Dec; 168():115670. PubMed ID: 37837883 [TBL] [Abstract][Full Text] [Related]
8. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy. Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335 [TBL] [Abstract][Full Text] [Related]
9. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli. Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469 [TBL] [Abstract][Full Text] [Related]
10. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress. Raij L; Tian R; Wong JS; He JC; Campbell KN Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373 [TBL] [Abstract][Full Text] [Related]
11. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Ilatovskaya DV; Staruschenko A Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930 [TBL] [Abstract][Full Text] [Related]
13. Podocyte hypertrophic stress and detachment precedes hyperglycemia or albuminuria in a rat model of obesity and type2 diabetes-associated nephropathy. Minakawa A; Fukuda A; Sato Y; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S Sci Rep; 2019 Dec; 9(1):18485. PubMed ID: 31811176 [TBL] [Abstract][Full Text] [Related]
14. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury. Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113 [TBL] [Abstract][Full Text] [Related]
15. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079 [TBL] [Abstract][Full Text] [Related]
16. In situ assessment of Mindin as a biomarker of podocyte lesions in diabetic nephropathy. Martins ALMDS; Bernardes AB; Ferreira VA; Wanderley DC; Araújo SA; do Carmo Neto JR; da Silva CA; Lira RCP; Araújo LS; Dos Reis MA; Machado JR PLoS One; 2023; 18(5):e0284789. PubMed ID: 37130106 [TBL] [Abstract][Full Text] [Related]
18. Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement. Schwarz A; Möller-Hackbarth K; Ebarasi L; Unnersjö Jess D; Zambrano S; Blom H; Wernerson A; Lal M; Patrakka J Sci Rep; 2019 Jun; 9(1):8888. PubMed ID: 31221975 [TBL] [Abstract][Full Text] [Related]